Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-21-032275)

Filing Details

Accession Number:: 0001493152-21-032275
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-22 16:05:22
Reporting Period:: 2021-12-20

Accepted Time:: 2021-12-22 16:05:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1359931	Protara Therapeutics Inc.	TARA	Biological Products, (No Disgnostic Substances) (2836)	204580525

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1595855	Opaleye Management Inc.	One Boston Place Suite 2600 Boston MA 02108		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-12-20	703	$6.49	2,496,209	No	4	P	Indirect	By Opaleye, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Opaleye, L.P.

Footnotes

Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume-weightedaverage purchase price of $6.49. The range of purchase prices on the transaction date was $6.49 per share.